Ray Dalio Accolade, Inc. Transaction History
Bridgewater Associates, LP
- $19.6 Billion
- Q1 2024
A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Accolade, Inc. stock. As of the latest transaction made, Bridgewater Associates, LP holds 68,830 shares of ACCD stock, worth $487,316. This represents 0.0% of its overall portfolio holdings.
Number of Shares
68,830
Previous 78,463
12.28%
Holding current value
$487,316
Previous $942,000
23.46%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding ACCD
# of Institutions
172Shares Held
68.5MCall Options Held
163KPut Options Held
492K-
Brown Advisory Inc5.85MShares$41.4 Million0.08% of portfolio
-
Black Rock Inc. New York, NY5.66MShares$40.1 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl5.61MShares$39.7 Million0.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$38.3 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY5.33MShares$37.7 Million0.01% of portfolio
About Accolade, Inc.
- Ticker ACCD
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 71,938,896
- Market Cap $509M
- Description
- Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and cli...